Updating the database of the Illinois Compiled Statutes (ILCS) is an ongoing process.
Recent laws may not yet be included in the ILCS database, but they are found on this site as
Public
Acts soon after they become law. For information concerning the relationship between statutes and Public Acts, refer to the
Guide.
Because the statute database is maintained primarily for legislative drafting purposes,
statutory changes are sometimes included in the statute database before they take effect.
If the source note at the end of a Section of the statutes includes a Public Act that has
not yet taken effect, the version of the law that is currently in effect may have already
been removed from the database and you should refer to that Public Act to see the changes
made to the current law.
(305 ILCS 5/5-16.8a) Sec. 5-16.8a. Rules concerning continuous glucose monitor coverage. The Department shall adopt rules to implement the changes made to Section 356z.59 of the Illinois Insurance Code, as applied to the medical assistance program. The rules shall, at a minimum, provide that: (1) the ordering provider must be a physician |
| licensed under the Medical Practice Act of 1987 or a certified nurse practitioner or physician assistant with a collaborative agreement with the physician; the ordering provider is not required to obtain continuing medical education in order to prescribe a continuous glucose monitor;
|
|
(2) continuous glucose monitors are not required to
|
| have an alarm when glucose levels are outside the pre-determined range; the capacity to generate predictive alerts in case of impending hypoglycemia; or the ability to transmit real-time glucose values and alerts to the patient and designated other persons;
|
|
(3) the beneficiary is not required to need intensive
|
|
(4) the beneficiary is not required to have a recent
|
| history of emergency room visits or hospitalizations related to hypoglycemia, hyperglycemia, or ketoacidosis;
|
|
(5) if the beneficiary has gestational diabetes, the
|
| beneficiary is not required to have suboptimal glycemic control that is likely to harm the beneficiary or the fetus;
|
|
(6) if a beneficiary has diabetes mellitus and the
|
| beneficiary does not meet the coverage requirements or if the beneficiary is in a population in which continuous glucose monitor usage has not been well-studied, requests shall be reviewed, on a case-by-case basis, for medical necessity and approved if appropriate; and
|
|
(7) prior authorization is required for a
|
| prescription of a continuous glucose monitor; once a continuous glucose monitor is prescribed, the prior authorization shall be approved for a 12-month period.
|
|
(Source: P.A. 103-639, eff. 7-1-24.)
|
